Physician profile
Mohammad Kousha
NPI 1326335381
$7,170.41
in general payments reported to CMS, 2019-2025
10 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920 · 2021: $15.63 · 2022: $315 · 2023: $108 · 2024: $5,673 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,050 · Food and Beverage: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,049.83 |
| Food and Beverage | $869.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,106.81 | 2024 | |
| Pulmonx Corporation | $731.00 | 2019-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Astrazeneca Pharmaceuticals LP | $643.59 | 2021-2025 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $317.26 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Getinge USA Sales, LLC | $106.24 | 2019 | |
| Genzyme Corporation | $104.21 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.38 | 2022-2025 | Ofev |
| Philips North America LLC | $40.74 | 2022-2025 | Vest Therapy Und |
| Mylan Specialty L.P. | $29.79 | 2023 | Yupelri |
| Grifols USA, LLC | $19.39 | 2023 | Prolastin-C Liquid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Kousha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.